Is it appropriate to administer phenobarbital 260 mg diluted in 25 mL of sodium chloride intravenously over 15 minutes?

Phenobarbital 260 mg in 25 mL Sodium Chloride Over 15 Minutes: Administration Safety

No, this administration rate is too fast and violates FDA safety guidelines—the maximum safe IV push rate for phenobarbital is 60 mg/min, which means 260 mg requires a minimum of 4-5 minutes, not 15 minutes as a diluted infusion. However, the 15-minute timeframe itself is acceptable if you're administering it as a controlled infusion rather than IV push.

Critical FDA Requirements

The FDA label explicitly states that IV injection rate should not exceed 60 mg/min for phenobarbital sodium 1. This is a hard safety limit to prevent:

• Severe respiratory depression
• Apnea
• Laryngospasm
• Hypotension or severe vasodilation
• Cardiovascular collapse

Your Specific Scenario Analysis

260 mg over 15 minutes = 17.3 mg/min, which is well within the safe rate limit of 60 mg/min 1.

Dilution Compatibility

The 25 mL volume in 0.9% sodium chloride is appropriate and stable. Research confirms phenobarbital sodium diluted to 10 mg/mL in normal saline remains stable for 4 weeks at 4°C 2. Your concentration (260 mg in 25 mL = 10.4 mg/mL) falls within validated parameters.

Administration Technique Requirements

You must observe these safety measures 1:

• Use a large vein (antecubital preferred)—avoid small veins on dorsum of hand/wrist
• Avoid varicose veins due to retarded circulation
• Aspirate before injection to prevent inadvertent intraarterial injection (can cause gangrene)
• Monitor continuously during administration: blood pressure, respiration, cardiac function
• Have resuscitation equipment immediately available including artificial ventilation capability

Clinical Context Matters

For Status Epilepticus

The FDA warns that phenobarbital may require 15 minutes or more to reach peak brain concentrations 1. If you're treating active seizures, injecting until convulsions stop will cause brain levels to overshoot and lead to severe barbiturate-induced depression. Give the dose, then wait for effect.

For Alcohol Withdrawal

The 260 mg dose aligns with established protocols. One study used 260 mg IV push × 1 followed by 130 mg every 15 minutes as needed 3, though front-loaded dosing (10 mg/kg over 30 minutes) showed better outcomes with lower intubation rates 3.

Common Pitfalls to Avoid

1. Intraarterial injection: Causes severe pain, arterial spasm, and potential gangrene. If patient complains of pain or you see white/cyanosed hand, stop immediately 1

2. Extravasation: Causes tissue necrosis. Treat with moist heat and 0.5% procaine injection into affected area 1

3. Concurrent CNS depressants: Avoid or use extreme caution with alcohol, benzodiazepines, or opioids—additive depression occurs 1. In one study, concurrent use led to over-sedation in 35% of cases 4

4. Neonatal use: This formulation contains benzyl alcohol and is contraindicated in neonates due to fatal "gasping syndrome" 1

Bottom Line

Your proposed administration (260 mg in 25 mL over 15 minutes) is safe and appropriate from a rate perspective. The infusion rate of 17.3 mg/min is well below the 60 mg/min maximum 1. Ensure you use proper IV access, monitor continuously, and have resuscitation equipment ready. The dilution is pharmaceutically stable 2.